Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2015-08-11 Interim / Quarterly Rep…
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2015
2015-08-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 10, 2015, reporting the issuance of a press release announcing financial results for the second quarter ended June 30, 2015. The text explicitly states that the press release is furnished as an exhibit and incorporated by reference, and the document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The length of the document is 2969 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, such a document that announces or furnishes a press release with financial results but does not itself contain the detailed financial data should be classified as a Regulatory Filing (RNS), as it does not meet the criteria for an Earnings Release (ER) or Interim Report (IR) itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2015-08-10 English
ARCADIA BIOSCIENCES, INC.
Major Shareholding Notification
2015-07-10 English
FROM 10-Q
Interim / Quarterly Report Q1 2015
2015-06-25 English
Regulatory Filings 2015
Regulatory Filings
2015-06-17 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 9, 2015. It includes an 'Other Events' section discussing the refiling of an Intellectual Property License Agreement originally filed as an exhibit to a Form S-1 registration statement. The document does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory filing reporting a specific event related to confidential treatment of an agreement exhibit. The length is 3269 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, this document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories.
2015-06-10 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.